-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 VRNVlPReu0uz+9E9HR7OpMMrl+A9e0FNLfBNk8eCrlOG87O3waF2QcPaSjGR6ZGm
 vMCStxfhfXZ6O1D0776p0A==

<SEC-DOCUMENT>0000927946-04-000162.txt : 20040809
<SEC-HEADER>0000927946-04-000162.hdr.sgml : 20040809
<ACCEPTANCE-DATETIME>20040809161518
ACCESSION NUMBER:		0000927946-04-000162
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20040714
ITEM INFORMATION:		Changes in registrant's certifying accountant
ITEM INFORMATION:		Financial statements and exhibits
FILED AS OF DATE:		20040809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		04961535

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>bas8ka.htm
<DESCRIPTION>BIOANALYTICAL FORM 8K/A
<TEXT>
<HTML>
<HEAD>
<Title>Bioanalytical Systems, Inc. - Form 8K/A</title></head>
<BODY>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<b>UNITED STATES</b><br>
<b>SECURITIES AND EXCHANGE COMMISSION</b></FONT><br>
<FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<b>Washington, D.C. 20549</b></font></P>
<br>

<hr width=30% noshade>

<p align=center><FONT FACE="Times New Roman, Times, Serif" size=4>
<B>AMENDMENT NO. 1</B><BR>
<BR>
<b>FORM 8-K</b><BR><BR>
<B>CURRENT REPORT</B><BR><br>
<b><small>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</small></b>
</font></p>
<hr width=30% noshade>

<p><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
Date of Report (Date of earliest event reported):&nbsp;&nbsp;<b>July 14, 2004</b>
</font></p>
<br>
<br>
<br>
<p align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=4>
<b><u>BIOANALYTICAL SYSTEMS, INC.</u></b><br>
<small><small><small>(Exact name of registrant as specified in its charter)</small></small></small>
</font></P>

<table width=95% border=0>
<tr valign=bottom><td align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<u>Indiana</u></font></td>
<TD ALIGN=center><FONT FACE="Times New Roman, Times, Serif" SIZE=3><u>
0-23357</u></font></td>
<TD ALIGN=center><FONT FACE="Times New Roman, Times, Serif" SIZE=3><u>
35-1345024</u></font></td></TR>

<TR VALIGN=TOP>
<TD ALIGN=center><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(State or other jurisdiction of<br>incorporation or organization)</font></TD>
<td align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(Commission File Number)</font></td>
<td align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(IRS Employer Identification No.)</font></td></TR>
<tr><TD><br></TD></tr>

<TR VALIGN=bottom><TD ALIGN=center><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
2701 Kent Avenue<br>
<u>West Lafayette, Indiana</u></font></TD>
<TD></TD> <td align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=3><br>
<u>47906-1382</u></font></td></TR>
<TR VALIGN=top><TD ALIGN=center><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(Address of principal executive offices)</font></TD><TD>
</TD><td align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(Zip Code)</font></td></TR>
<tr><TD></TD></tr>
<TR VALIGN=top><TD> </TD><TD align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=3><u>
(765) 463-4527</u></font></TD></TR>
<TR VALIGN=top>
<TD>&nbsp;</TD><TD ALIGN=center><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(Registrant's telephone number, including area code)</font></TD></TR>
</TABLE>



<PAGE>


<!-- MARKER FORMAT-SHEET="Body - No Indent" FSL="Default" -->
<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
This amendment number 1 to form 8-K amends the form 8-K filed by the registrant on
July 21, 2004 (&#147;Original Form 8-K&#148;).</FONT></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
<B>Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Changes in Registrant's Certifying
Accountants.</B></font></P>

<!-- MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Default" -->
<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The response to Item 4 in the
Original Form 8-K is deleted and replaced with the following:</FONT></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Previous Independent Accountants</font></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 1-TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=9%>&nbsp;</TD>
<TD WIDTH=91%><DIV ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
On July 14, 2004, the Company&#146;s Audit Committee of the Board of Directors
approved the dismissal of the Company&#146;s independent public accountants,
Ernst &amp; Young, LLP (&#147;E&amp;Y&#148;) and the engagement of KPMG, LLP
(&#147;KPMG&#146;).</FONT></DIV></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 1-TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=9%>&nbsp;</TD>
<TD WIDTH=91%><DIV ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
The reports of E&amp;Y for the past two fiscal years ended September 30, 2003
and 2002, contained no adverse opinion or disclaimer of opinion and were not
qualified or modified as to uncertainty, audit scope, or accounting
principles.&nbsp;</FONT></DIV></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 1-TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=9%>&nbsp;</TD>
<TD WIDTH=91%><DIV ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
In connection with its audits for the two most recent fiscal years ended
September 30, 2003 and 2002 and through July 14, 2004, there have been no
disagreements with E&amp;Y on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure, which
disagreements, if not resolved to the satisfaction of E&amp;Y, would have caused
them to make reference to the subject matter of the disagreement in connection
with their report on the financial statements for such period.</FONT></DIV></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 1-TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=9%>&nbsp;</TD>
<TD WIDTH=91%><DIV ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
During the two most recent fiscal years ended September 30, 2003 and 2002, and
through July 14, 2004, there have been no reportable events (as defined in
Regulation S-K, Item 304(a)(1)(v)), except for a material weakness in the
Company&#146;s internal control for the year ended September 30, 2003 which was
identified by E&amp;Y and disclosed in Item 9A in the Company&#146;s Annual
Report on Form 10-K for the year ended September 30, 2003. &nbsp;Specifically,
the independent auditors noted that the Company&#146;s internal control failed
to timely alert management of potential loan covenant noncompliance. &nbsp;The
Company did not have procedures in place to monitor near-term future financial
position and results of operations to enable it to take operational action in
the event of potential loan covenant noncompliance. &nbsp;The Company has taken
measures to correct this material weakness in the form of enhancing its planning
process and creating procedures to more timely identify credit agreement
compliance issues. E&amp;Y discussed this issue with the Audit Committee of the
Board of Directors, and has been authorized by the Company to respond fully to
the inquiries of KPMG.</FONT></DIV></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 1-TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=9%>&nbsp;</TD>
<TD WIDTH=91%><DIV ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
E&amp;Y has furnished the Company with a letter addressed to the Securities and
Exchange Commission (the &#147;Commission&#148;) stating that it agrees with the
above statements. A copy of such letter dated August 5, 2004 is filed as Exhibit
16.1 to this Form 8-K.</FONT></DIV></TD>
</TR>
</TABLE>
<BR>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
New Independent Accountants</font></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 1-TNR" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=9%>&nbsp;</TD>
<TD WIDTH=91%><DIV ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
The Company has engaged KPMG as its principal independent accountants effective
as of July 19, 2004. &nbsp; During the two most recent fiscal years ended
September 30, 2003 and 2002, and through July 19, 2004, the Company has not
consulted with KPMG regarding either:&nbsp; (i) the application of accounting
principles to a specified transaction, either completed or proposed; or the type
of audit opinion that might be rendered on the Company&#146;s financial
statements; or (ii) any matter that was either the subject of a disagreement (as
that term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related in
instructions to that Item) or a reportable event (as that term is defined in
Item 304(a)(1)(v) of Regulation S-K).&nbsp;</FONT></DIV></TD>
</TR>
</TABLE>
<BR>


<PAGE>


<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
<B>Item 7.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Exhibit 16.1 filed with the
Original Form 8-K is deleted and replaced with Exhibit 16.1 attached
hereto.</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits
</font></P>

<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=25%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<B>Number</B><hr width=25%>
<BR>
16.1</FONT></div></TD>
<TD WIDTH=75%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<B>Exhibit</B><hr>
<BR>
Letter dated August 5, 2004 from Ernst &amp; Young, LLP to the Securities and
Exchange Commission
</FONT></TD>
</TR>
</TABLE>
<BR>




<PAGE>



<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" size=2>
<B>SIGNATURES</B></font></P>
<BR>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized.</font></P>



<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=60%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<BR>
<BR>
<BR>
Date:&nbsp;&nbsp;August 5, 2004</FONT></TD>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<B>Bioanalytical Systems, Inc.<BR>
(Registrant)</B>
</FONT></Td>
</TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TH WIDTH=60%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</FONT></TH>
<TH WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/&nbsp;Michael R. Cox&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<hr>
Michael R. Cox<BR>
<I>VP-Finance, Chief Financial Officer and<BR>
Treasurer</I>
</FONT></TH>
</TR>
</TABLE>


</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16
<SEQUENCE>2
<FILENAME>exhibit161.htm
<DESCRIPTION>EXHIBIT 16.1
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 16.1 - Bioanalytical Systems, Inc.</TITLE>
</HEAD>
<BODY>

<!-- MARKER FORMAT-SHEET="Heading Center Bold" FSL="Workstation" -->
<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>Exhibit 16.1</U></FONT></H1>

<!-- MARKER FORMAT-SHEET="Indented Head Left" FSL="Workstation" -->
<P ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
August 5, 2004<BR>
<BR>
<BR>
<BR>
Securities and Exchange Commission<BR>
450 Fifth Street, N.W.<BR>
Washington, DC 20549<BR>
<BR>
Gentlemen:</FONT></P>

<!-- MARKER FORMAT-SHEET="Body - No Indent" FSL="Workstation" -->
<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
We have read Item 4 of Amendment No. 1 to Form 8-K dated July 14, 2004, of Bioanalytical Systems,
Inc. and are in agreement with the statements contained in the paragraphs of
4(a) on page 2 therein. We have no basis to agree or disagree with other
statements of the registrant contained therein.</FONT></P>

<!-- MARKER FORMAT-SHEET="Body - No Indent" FSL="Workstation" -->
<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Regarding the registrant&#146;s statement concerning the material weakness in
internal control, included in the fourth paragraph of 4(a) on page 2 therein, we
had considered such matter in determining the nature, timing and extent of
procedures performed in our audit of the registrant&#146;s 2003 financial
statements.</FONT></P>

<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=60%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Very truly yours,<BR>
<BR>
/s/&nbsp;&nbsp;Ernst &amp; Young LLP</FONT></TD>
</TR>
</TABLE>
<BR>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
